190 related articles for article (PubMed ID: 28299946)
1. Single Institute Experience With Methylphenidate and American Ginseng in Cancer-Related Fatigue.
Chang YD; Smith J; Portman D; Kim R; Oberoi-Jassal R; Rajasekhara S; Davis M
Am J Hosp Palliat Care; 2018 Jan; 35(1):144-150. PubMed ID: 28299946
[TBL] [Abstract][Full Text] [Related]
2. Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial.
Bruera E; Yennurajalingam S; Palmer JL; Perez-Cruz PE; Frisbee-Hume S; Allo JA; Williams JL; Cohen MZ
J Clin Oncol; 2013 Jul; 31(19):2421-7. PubMed ID: 23690414
[TBL] [Abstract][Full Text] [Related]
3. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
Bruera E; Valero V; Driver L; Shen L; Willey J; Zhang T; Palmer JL
J Clin Oncol; 2006 May; 24(13):2073-8. PubMed ID: 16648508
[TBL] [Abstract][Full Text] [Related]
4. High-Dose Asian Ginseng (Panax Ginseng) for Cancer-Related Fatigue: A Preliminary Report.
Yennurajalingam S; Reddy A; Tannir NM; Chisholm GB; Lee RT; Lopez G; Escalante CP; Manzullo EF; Frisbee Hume S; Williams JL; Cohen L; Bruera E
Integr Cancer Ther; 2015 Sep; 14(5):419-27. PubMed ID: 25873296
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with response to methylphenidate in advanced cancer patients.
Yennurajalingam S; Palmer JL; Chacko R; Bruera E
Oncologist; 2011; 16(2):246-53. PubMed ID: 21282671
[TBL] [Abstract][Full Text] [Related]
6. The use of methylphenidate to relieve fatigue.
Rojí R; Centeno C
Curr Opin Support Palliat Care; 2017 Dec; 11(4):299-305. PubMed ID: 28885263
[TBL] [Abstract][Full Text] [Related]
7. Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial.
Kerr CW; Drake J; Milch RA; Brazeau DA; Skretny JA; Brazeau GA; Donnelly JP
J Pain Symptom Manage; 2012 Jan; 43(1):68-77. PubMed ID: 22208450
[TBL] [Abstract][Full Text] [Related]
8. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report.
Bruera E; Driver L; Barnes EA; Willey J; Shen L; Palmer JL; Escalante C
J Clin Oncol; 2003 Dec; 21(23):4439-43. PubMed ID: 14645434
[TBL] [Abstract][Full Text] [Related]
9. Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2.
Barton DL; Liu H; Dakhil SR; Linquist B; Sloan JA; Nichols CR; McGinn TW; Stella PJ; Seeger GR; Sood A; Loprinzi CL
J Natl Cancer Inst; 2013 Aug; 105(16):1230-8. PubMed ID: 23853057
[TBL] [Abstract][Full Text] [Related]
10. Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial.
Mendonça DA; Menezes K; Jog MS
Mov Disord; 2007 Oct; 22(14):2070-6. PubMed ID: 17674415
[TBL] [Abstract][Full Text] [Related]
11. A phase II study of methylphenidate for the treatment of fatigue.
Hanna A; Sledge G; Mayer ML; Hanna N; Einhorn L; Monahan P; Daggy J; Bhatia S
Support Care Cancer; 2006 Mar; 14(3):210-5. PubMed ID: 16096772
[TBL] [Abstract][Full Text] [Related]
12. Use of methylphenidate for the management of fatigue in Chinese patients with cancer.
Siu SW; Law M; Liu RK; Wong KH; Soong IS; Kwok AO; Ng KH; Lam PT; Leung TW
Am J Hosp Palliat Care; 2014 May; 31(3):281-6. PubMed ID: 23650644
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Methylphenidate on Fatigue in Advanced Cancer: An Aggregated N-of-1 Trial.
Mitchell GK; Hardy JR; Nikles CJ; Carmont SA; Senior HE; Schluter PJ; Good P; Currow DC
J Pain Symptom Manage; 2015 Sep; 50(3):289-96. PubMed ID: 25896104
[TBL] [Abstract][Full Text] [Related]
14. Psychostimulants for the management of cancer-related fatigue: a systematic review and meta-analysis.
Minton O; Richardson A; Sharpe M; Hotopf M; Stone PC
J Pain Symptom Manage; 2011 Apr; 41(4):761-7. PubMed ID: 21251796
[TBL] [Abstract][Full Text] [Related]
15. Improved cancer-related fatigue in a randomised clinical trial: methylphenidate no better than placebo.
Centeno C; Rojí R; Portela MA; De Santiago A; Cuervo MA; Ramos D; Gandara A; Salgado E; Gagnon B; Sanz A
BMJ Support Palliat Care; 2022 Jun; 12(2):226-234. PubMed ID: 33168668
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of methylphenidate for fatigue in advanced cancer patients: a preliminary study.
Sugawara Y; Akechi T; Shima Y; Okuyama T; Akizuki N; Nakano T; Uchitomi Y
Palliat Med; 2002 May; 16(3):261-3. PubMed ID: 12047006
[No Abstract] [Full Text] [Related]
17. Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial.
Moraska AR; Sood A; Dakhil SR; Sloan JA; Barton D; Atherton PJ; Suh JJ; Griffin PC; Johnson DB; Ali A; Silberstein PT; Duane SF; Loprinzi CL
J Clin Oncol; 2010 Aug; 28(23):3673-9. PubMed ID: 20625123
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic treatment options for cancer-related fatigue: current state of clinical research.
Breitbart W; Alici Y
Clin J Oncol Nurs; 2008 Oct; 12(5 Suppl):27-36. PubMed ID: 18842522
[TBL] [Abstract][Full Text] [Related]
19. Phase II, randomised, double-blind, placebo-controlled trial of methylphenidate for reduction of fatigue levels in patients with prostate cancer receiving LHRH-agonist therapy.
Richard PO; Fleshner NE; Bhatt JR; Hersey KM; Chahin R; Alibhai SM
BJU Int; 2015 Nov; 116(5):744-52. PubMed ID: 24684534
[TBL] [Abstract][Full Text] [Related]
20. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
